578 LONG-TERM OUTCOME OF VENTRICULAR TACHYCARDIA CATHETER ABLATION IN PATIENTS WITH CHRONIC CORONARY TOTAL OCCLUSION [PDF]
, 2022 Francesco Flore +9 more
openalex +1 more source
Inflammatory Cytokines as Early Predictors of Weaning Failure From Extracorporeal Life Support
Artificial Organs, EarlyView.Levels of IL‐8 and IL‐6 and their dynamics are reliable early predictors of ECLS weaning failure. ABSTRACT Background Weaning from extracorporeal life support (ECLS) in patients with refractory shock still remains a complex decision. Despite considerable advances in ECLS management, reliable biomarkers to predict weaning success are still not available.
Kostiantyn Kozakov +11 more
wiley +1 more source
Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction [PDF]
, 2019 Alexandra Schratter +2 more
openalex +1 more source
Artificial Organs, EarlyView.Percutaneous femoro‐femoral V‐A ECMO cannulation was associated with more than a two‐fold lower risk of site bleeding and nearly a six‐fold lower risk of infection compared with surgical cut‐down, with no difference in limb ischemia. Absence of distal perfusion catheterization and larger arterial cannula size were additional modifiable ischemia risk ...
Axel Dimberg +3 more
wiley +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
British Journal of Pharmacology, EarlyView.Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
218-03: Infarct transmurality as a criterion for first-line endo-epicardial substrate–guided ventricular tachycardia ablation in ischemic cardiomyopathy [PDF]
, 2016 Juan Acosta +14 more
openalex +1 more source
Catheter ablation for ventricular tachyarrhythmia in patients with channelopathies
Journal of Arrhythmia, 2016 Drug treatment and/or implantable cardioverter defibrillator (ICD) implantation are the most widely accepted first-line therapies for channelopathic patients who have recurrent syncope, sustained ventricular tachycardia (VT), or documented ventricular ...
Nobuyuki Murakoshi, MD, PhD +1 more
doaj +1 more source
69-03: Safety, Long-Term Outcomes, and Predictors of Recurrence after First-Line Combined Endoepicardial Ventricular Tachycardia Substrate Ablation in Arrhythmogenic Cardiomyopathy. A Prospective Multiceter Study [PDF]
, 2016 Juan Acosta +12 more
openalex +1 more source
British Journal of Pharmacology, EarlyView.The data that support the findings of this study are available from the corresponding author upon reasonable request. Some data may not be made available because of privacy or ethical restrictions. Background and Purpose Ventricular arrhythmias are a leading cause of death among patients with cardiovascular diseases and are associated with elevated ...
Felipe de Jesús Salazar‐Ramírez +13 more
wiley +1 more source
An inappropriate shock after reprogramming tachycardia zones
Journal of Arrhythmia, 2019 A patient with an implantable cardioverter‐defibrillator (ICD) (Abbott®) had episodes of slow monomorphic ventricular tachycardia (VT) and his ICD was programmed with three tachycardia zones. During the follow‐up, he received an inappropriate shock. Upon
Rita Marinheiro +9 more
doaj +1 more source